Bigger Foot: Kaposi's Sarcoma

• Published in: The American journal of medicine Vol. 128; no. 9; pp. 959 - 962
• Main Authors: Rapaka, Rekha R., MD, PhD, Fischer, Max, MD, Finucane, Thomas E., MD, Mwakingwe, Agnes, MD, PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-09-2015; Elsevier Sequoia S.A
• Subjects: Acquired Immunodeficiency Syndrome - complications; Acquired Immunodeficiency Syndrome - immunology; Adult; CD4 Lymphocyte Count; Cellulitis; Cellulitis - diagnosis; Clinical outcomes; Dermatology; Foot - pathology; Foot Diseases - complications; Foot Diseases - diagnosis; Humans; Internal Medicine; Kaposi's sarcoma; Kaposis sarcoma; Lymphedema; Male; Medical treatment; Nodule; Oncology; Rash; Sarcoma, Kaposi - complications; Sarcoma, Kaposi - diagnosis; Skin Neoplasms - complications; Skin Neoplasms - diagnosis; Rash; Lymphedema; Cellulitis; Kaposi's sarcoma; Nodule
• ISSN: 0002-9343; 1555-7162
• DOI: 10.1016/j.amjmed.2015.05.005

A normal CD4+ T cell count does not preclude opportunistic infection in an HIV-positive patient. This point was illustrated by the evaluation of a 33-year-old African American man with a history of asymptomatic HIV-1 infection. He presented to the Johns Hopkins Bayview Medical Center after 2 days of fever, chills, right lower-extremity pain, erythema, and swelling. His CD4+ T cell count was 774 cells/μL on presentation, and he had no history of treatment with highly active antiretroviral therapy (HAART) or of an AIDS-defining illness. Here, Rapaka et al present their assessment, diagnosis and management of the patient diagnosed with Kaposi's sarcoma.